Literature DB >> 16202455

Are there any gender differences in frequency of self-reported somatic symptoms of depression?

Amy Wenzel1, Robert A Steer, Aaron T Beck.   

Abstract

BACKGROUND: The purpose of this study was to evaluate whether self-reported somatic symptoms of depression, as measured by the Beck Depression Inventory-II (BDI-II), are more frequent in women than in men with major depressive disorder.
METHODS: A sample of 105 male and 105 female adult psychiatric outpatients diagnosed with major depressive disorder was classified according to endorsed changes in appetite, changes in sleeping pattern, and fatigue (i.e., "somatic depression") symptoms on the BDI-II.
RESULTS: The female to male ratio of somatic symptoms was approximately 2:1. Subsequent analyses found that change in appetite robustly distinguished between women and men and that fatigue partially distinguished between women and men. LIMITATIONS: The sample was largely Caucasian and composed of patients with high rates of comorbidity who presented to a service known for specializing in cognitive therapy.
CONCLUSIONS: In outpatients with major depressive disorder, the higher prevalence of "somatic depression" in women is largely attributable to changes in appetite.

Entities:  

Mesh:

Year:  2005        PMID: 16202455     DOI: 10.1016/j.jad.2005.06.009

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  20 in total

1.  Screening for depression in arthritis populations: an assessment of differential item functioning in three self-reported questionnaires.

Authors:  Jinxiang Hu; Michael M Ward
Journal:  Qual Life Res       Date:  2017-06-17       Impact factor: 4.147

2.  Self-reported versus informant-reported depressive symptoms in adults with mild intellectual disability.

Authors:  I Mileviciute; S L Hartley
Journal:  J Intellect Disabil Res       Date:  2013-07-31

3.  Characterizing depression and comorbid medical conditions in African American women in a primary care setting.

Authors:  Ruth S Shim; Peter Baltrus; L DiAnne Bradford; Kisha B Holden; Edith Fresh; Lonnie E Fuller
Journal:  J Natl Med Assoc       Date:  2013       Impact factor: 1.798

4.  The role of gender and race in the relation between adolescent distress tolerance and externalizing and internalizing psychopathology.

Authors:  Stacey B Daughters; Stephanie M Gorka; Jessica F Magidson; Laura Macpherson; C J Seitz-Brown
Journal:  J Adolesc       Date:  2013-09-13

5.  Factor analysis of the clustering of common somatic symptoms: a preliminary study.

Authors:  Chung-Huang Tsai
Journal:  BMC Health Serv Res       Date:  2010-06-10       Impact factor: 2.655

6.  Predictors of somatic symptom severity: The role of cumulative history of trauma and adversity in a diverse community sample.

Authors:  Tamra Burns Loeb; Nataria T Joseph; Gail E Wyatt; Muyu Zhang; Dorothy Chin; April Thames; Yvorn Aswad
Journal:  Psychol Trauma       Date:  2017-11-20

Review 7.  Depression Symptom Severity and Cardiorespiratory Fitness in Healthy and Depressed Adults: A Systematic Review and Meta-Analysis.

Authors:  Theodoros Papasavvas; Robert O Bonow; Mohammad Alhashemi; Dominic Micklewright
Journal:  Sports Med       Date:  2016-02       Impact factor: 11.136

8.  Fibromyalgia among major depression disorder females compared to males.

Authors:  Tali Vishne; Lea Fostick; Alicia Silberman; Marina Kupchick; Alan Rubinow; Haward Amital; Daniela Amital
Journal:  Rheumatol Int       Date:  2008-02-02       Impact factor: 2.631

9.  A life-course and time perspective on the construct validity of psychological distress in women and men. Measurement invariance of the K6 across gender.

Authors:  Aline Drapeau; Dominic Beaulieu-Prévost; Alain Marchand; Richard Boyer; Michel Préville; Sylvia Kairouz
Journal:  BMC Med Res Methodol       Date:  2010-07-21       Impact factor: 4.615

Review 10.  Somatic symptoms in depression.

Authors:  Hans-Peter Kapfhammer
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.